AbbVie (NYSE: ABBV)
AbbVie Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
Dividend Kings of 2024
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
3 Dividend Stocks to Double Up on Right Now
The stories for these great dividend stocks are better than many might think.
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
AbbVie's returns haven't been great this year, but investors shouldn't overlook this promising growth stock.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
These dividend stocks are ideal for investors seeking long-term passive income.
A Must-Own Stock for Any Portfolio
This company offers growth, high yield, and dividend growth.
2 Billion More Reasons to Buy AbbVie Stock
This pharma giant just made a smart strategic acquisition.
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Revenue growth during what should be a disastrous patent cliff is encouraging.
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Valuation
Earnings Transcripts
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
ABBV earnings call for the period ending March 31, 2024.
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2023.
AbbVie (ABBV) Q3 2023 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2023.
AbbVie (ABBV) Q2 2023 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.